Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jon Viljar Norvik"'
Autor:
Karl Marius Brobak, Toralf Melsom, Bjørn Odvar Eriksen, Aud Høieggen, Jon Viljar Norvik, Marit Dahl Solbu
Publikováno v:
Kidney & Blood Pressure Research, Vol 49, Iss 1, Pp 184-195 (2024)
Introduction: Subclinical kidney dysfunction may contribute to salt-sensitive hypertension. We assessed the association between the urinary sodium-potassium ratio (Na/K ratio) and blood pressure (BP) in a general population cohort without diabetes, c
Externí odkaz:
https://doaj.org/article/7a31261a17094a96a9b0dd830d723485
Autor:
Toralf Melsom, Marit Dahl Solbu, Jørgen Schei, Vidar Tor Nyborg Stefansson, Jon Viljar Norvik, Trond Geir Jenssen, Tom Wilsgaard, Bjørn Odvar Eriksen
Publikováno v:
Kidney International Reports, Vol 3, Iss 4, Pp 817-824 (2018)
Introduction: A minimal increase in the albumin-to-creatinine ratio (ACR) predicts cardiovascular disease and mortality, but whether it predicts kidney function loss in nondiabetic persons is unclear. We investigated the association between ACR in th
Externí odkaz:
https://doaj.org/article/5524d97ab2f1485f9206fc014dac252e
Autor:
Nikoline B. Rinde, Inger Therese Enoksen, Toralf Melsom, Ole Martin Fuskevåg, Bjørn Odvar Eriksen, Jon Viljar Norvik
Publikováno v:
Kidney Int Rep
INTRODUCTION: Nitric oxide (NO) deficiency is associated with endothelial dysfunction, hypertension, atherosclerosis, and chronic kidney disease (CKD). Reduced NO bioavailability is hypothesized to play a vital role in kidney function impairment and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e4590469a6d8178ef243d44a83b4d2e
https://europepmc.org/articles/PMC10105054/
https://europepmc.org/articles/PMC10105054/
Autor:
Nikoline Balteskard Rinde, Inger Therese Enoksen, Toralf Melsom, Ole-Martin Fuskevag, Bjørn Odvar Eriksen, Jon Viljar Norvik
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Nitric oxide (NO) deficiency is associated with endothelial dysfunction, hypertension, vasoconstriction, atherosclerosis and chronic kidney disease (CKD) [1]. Reduced NO bioavailability is hypothesized to play a vital role in kidn
Publikováno v:
The Journal of Clinical Hypertension
Data suggest that renal denervation (RDN) in treatment-resistant hypertension (TRHT) is safe in terms of renal function. However, most studies report kidney function as creatinine-based estimated glomerular filtration rate (eGFR), which may be biased
Autor:
Vidar Tor Nyborg Stefansson, Toralf Melsom, Jon Viljar Norvik, Renathe Rismo, Trond Jenssen, Bjørn Odvar Eriksen, Marit Dahl Solbu, Inger Therese T Enoksen
Publikováno v:
Kidney International Reports
Introduction Although lower high-density lipoprotein cholesterol (HDL-C) levels are considered a risk factor for cardiovascular disease (CVD), experimental evidence suggest that aging, inflammation, and oxidative stress may remodel HDL-C, leading to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::775ff1abe51090c5381fa18f405e9164
https://hdl.handle.net/10037/22499
https://hdl.handle.net/10037/22499
Autor:
Laura H. Mariani, Helen C. Looker, Jennifer L. Harder, Viji Nair, Marit Dahl Solbu, Toralf Melsom, Vidar Tor Nyborg Stefansson, Trond Jenssen, Jørgen Schei, Robert G. Nelson, Jon Viljar Norvik, Matthias Kretzler, Bjørn Odvar Eriksen, William C. Knowler
Publikováno v:
American Journal of Kidney Diseases. 73:777-785
Rationale & Objective - An elevated glomerular filtration rate (GFR), or renal hyperfiltration, may predispose individuals to subsequent rapid GFR decline in diabetes, obesity, and metabolic syndrome. Although this hypothesis is supported by results
Autor:
Vidar Tor Nyborg Stefansson, Toralf Melsom, Inger Therese T Enoksen, Marit Dahl Solbu, Jon Viljar Norvik, Bjørn Odvar Eriksen, Dmitri Svistounov
Background Age-related reduction of glomerular filtration rate (GFR) is a major contributor to the global chronic kidney disease (CKD) epidemic. We investigated whether baseline serum levels of the pro-fibrotic matrix metalloproteinase 2 (MMP2), MMP7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cae5251c0e4a795235d6a9b6cab8cff
https://hdl.handle.net/10037/23837
https://hdl.handle.net/10037/23837
Autor:
Jon Viljar Norvik, Karl Marius Brobak, Runa Marie Andreassen, Toralf Melsom, Marit Dahl Solbu
Publikováno v:
Journal of Hypertension. 39:e111-e112
Autor:
Terje K. Steigen, T.A. Hanssen, A. Miroslawska, Marit Dahl Solbu, Petter Fosse Gjessing, Ole M. Fuskevåg, Jon Viljar Norvik
Publikováno v:
Clinical nutrition (Edinburgh, Scotland). 40(4)
Summary Background & aims Denervation of renal sympathetic nerves (RDN) is an invasive endovascular procedure introduced as an antihypertensive treatment with a potential beneficial effect on insulin resistance (IR). We have previously demonstrated a